Table 4 Neurological and mental disorder diagnoses and medication on discharge and 12-month post-discharge follow-up outcome regarding movement disturbances and mental disorder- and neurological diagnoses
Case No | Hospitalization duration (in days) | Discharge neurological diagnosis | Discharge mental disorder diagnosis | Medication at discharge | 12-month post-discharge follow-up outcome |
|---|---|---|---|---|---|
1 | 45 | Drug-induced parkinsonism Mild Cognitive Impairment due to Alzheimer’s disease | Organic mood disorder | Duloxetine (90), donepezil (5) | No movement disturbances Dementia due to Alzheimer’s disease |
2 | 40 | Idiopathic tremor | Severe depressive episode of recurrent depressive disorder | Quetapine (25), duloxetine (60), clonazepam (2), levothyroxine sodium (100 μg) | Idiopathic tremor |
3 | 90 | Drug-induced parkinsonism | Severe depressive episode of recurrent depressive disorder | Risperidone (4), paroxetine (20), mirtazapine (60), alprazolam (4), biperiden (4) | No movement disturbances |
4 | 120 | Drug-induced parkinsonism Tardive dyskinesia Mild Cognitive Impairment due to Alzheimer’s disease | Severe depressive episode of recurrent depressive disorder | Quetiapine (150), trazodone (50), mirtazapine (45), lorazepam (7.5), biperiden (2), pindolol (5) | Tardive dyskinesia Dementia due to Alzheimer’s disease |
5 | 60 | Drug-induced parkinsonism | Organic mood disorder | Quetiapine (50), duloxetine (90), lorazepam (0.5), levodopa/benserazide (100/25), amiloride, hydrochloride/hydrochlorothiazide (5/50) | Parkinsonism Persistent psychotic symptoms |
6 | 35 | Parkinson’s disease | Organic mood disorder | Escitalopram (40), lorazepam (1), levodopa/benserazide (600/150), amantadine (100) | Parkinsonism |
7 | 100 | Drug-induced parkinsonism | Severe depressive episode of recurrent depressive disorder | Duloxetine (60), mirtazapine (45), lorazepam (1), levodopa/benserazide (200/50) | No movement disturbances Dementia due to Alzheimer’s disease |
8 | 40 | Vascular parkinsonism Microvascular ischemic brain disease | Organic mood disorder | Duloxetine (30), rivastigmine (4.6), levodopa/benserazide (200/50), ilbesartan (150) | Parkinsonism Vascular dementia |